Alveolar Macrophages and Toll-Like Receptor 4 Mediate Ventilated Lung Ischemia Reperfusion Injury in Mice

Anesthesiology - United States
doi 10.1097/aln.0b013e31826a4ae3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Toll-Like Receptor 4 Is Protective Against Neonatal Murine Ischemia-Reperfusion Intestinal Injury

Journal of Pediatric Surgery
MedicineChild HealthSurgeryPediatricsPerinatology
2010English

MicroRNA-421 Improves Ischemia/Reperfusion Injury via Regulation Toll-Like Receptor 4 Pathway

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

On the Edge: Targeting Toll-Like Receptor 2 in Ischemia/Reperfusion Injury

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Impact of Toll-Like Receptor 4 Deficiency on the Response to Uterine Ischemia/Reperfusion in Mice

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2013English

2422Nanoparticle-Mediated Delivery of Toll-Like Receptor 4 Antagonist to Monocytes and Ischemic Myocardium Enhances Cardioprotection Against Ischemia-Reperfusion Injury in Mice

European Heart Journal
Cardiovascular MedicineCardiology
2018English

Toll-Like Receptor 4 Monoclonal Antibody Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2014English

Toll-Like Receptor-4 and Lipoprotein Accumulation in Macrophages

Trends in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2009English

DC-SIGN and Toll-Like Receptor 4 Mediate Oxidized Low-Density Lipoprotein-Induced Inflammatory Responses in Macrophages

Scientific Reports
Multidisciplinary
2017English

Ozone-Induced Lung Injury and Sterile Inflammation. Role of Toll-Like Receptor 4

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy